HOME >> MEDICINE >> NEWS
Rutgers study shows learning ability under stress still strong in Prozac-treated females

NEW BRUNSWICK/PISCATAWAY, N.J. The drug Prozac protects a female's learning abilities after a stressful or traumatic event, according to a new research study conducted at Rutgers, The State University of New Jersey.

"Depression is a devastating illness that is often accompanied in females by an inability to concentrate and learn," said Tracey J. Shors, an associate professor in the department of psychology. "Our data show that while Prozac is an effective drug for treating depression, it also protects females from the adverse effects of stress on learning."

Shors will present her findings in a paper, "Serontinergic Antidepressants Protect Females from the Adverse Effects of Stressful Experience on Learning," at the Society for Neuroscience annual meeting in Orlando, Fla., Nov. 1-6.

Shors and her research team, Benedetta Leuner, Jacqueline Falduto and Sabrina Mendolia, studied adult female rats treated with the antidepressant Prozac and a control group that received no treatment. They found that after a stressful event, learning was impaired in the control group but not in the group treated with Prozac. The researchers also found that only chronic treatment with Prozac was effective, which is consistent with reported efficacy of Prozac in patients with depression and other mental disorders.

"Importantly," Shors pointed out, "unstressed females treated with Prozac did not differ from unstressed, untreated females, indicating that Prozac itself did not affect learning."

Shors noted that males and females differ in their responses to stressful experiences. The researchers have found that exposure to a stressful experience that impairs new learning in females actually enhances new learning in males.

Since twice as many women experience depression and other stress-related mental illnesses as men, these data underscore the need to include females in research aimed at understanding the biology of mental illness, Sh
'"/>

Contact: Miguel Tersy
mtersy@ur.rutgers.edu
732-932-7084 x616
Rutgers, the State University of New Jersey
28-Oct-2002


Page: 1 2

Related medicine news :

1. Rutgers College of Nursing faculty member is funded to develop an interactive computer system
2. Rutgers-Newark researchers link early movement, brain development
3. Rutgers-developed biomaterial drives a technology transfer story toward success
4. Rutgers scientists pinpoint brain cells involved in drug addiction relapse
5. Rutgers researcher: Brains in dyslexic children can be rewired to improve reading skills
6. Rutgers wins funds to create online index of moving brain images
7. Rutgers researcher finds brain connections may reorganize in Parkinsons disease
8. Rutgers research shows caffeine may prevent skin cancer
9. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
10. International Thiamine (Vitamin B-1) Conference at Rutgers Newark
11. Rutgers develops virtual reality treatment for hand impairment in chronic stroke patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... ... Only two months after the official release of The Private Collection – Edition 2017 ... initiated a second print-run of its lavish luxury travel coffee table book. , ... in at more than six kilos, retails at EUR 1,000 per copy and is ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is here, ... predict that 47 percent of all jobs in the United States may be taken ... The day of the aggressive know-it-all who steamrolls over colleagues is drawing to a ...
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The International ... 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected ... will be showcased and the winner revealed at the 31st annual iaedp Symposium, March ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australie, le 24 février 2017 ITL Limited, ( ... diversifiée innovante, est ravie d,annoncer les excellents résultats semestriels ... période précédente correspondante. Une présentation complète « Résultats et mise ... consultée ici . Faits marquants ... 2,12 millions $ (Déc. 2015 : 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 23, 2017 Non-alcoholic steatohepataitis (NASH) ... various drugs being developed for the treatment ... drugs that are in various phases of ... focuses on novel pharmacologic drugs & regenerative ... therapies, recombinant proteins and RNA-based therapeutics, but ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
Breaking Medicine Technology:
Cached News: